Abstract:Introduction: Secondary inflammation is a well-established cause of injury in intracerebral hemorrhage (ICH). One potential treatment for ICH limits inflammation through targeted metabolic modulation of immune cells, but leukocyte activation states in ICH are poorly defined. Using single-cell RNA sequencing (scRNA-seq) of patient hematoma evacuates, we characterized the inflammatory and metabolic profile of over a dozen identifiable leukocyte populations. This research provides insight into the dynamics of immune activation in ICH. Methods: Evacuated hematoma and peripheral blood samples from 8 ICH patients (62 ± 2.1 years) were collected via minimally invasive surgery (n=5) or craniotomy (n=3) (Fig. 1a). Collection time ranged from 0 to 4 days after ICH onset (1.5 ± 0.5 days). scRNA-seq was done on the 10X Genomics platform and analyzed using Seurat. Human monocyte-derived macrophage cultures were stimulated with S100A9 and IL-1β, two ICH-relevant inflammatory molecules, or LPS. Echinomycin and 2-deoxy-D-glucose were used to inhibit HIF signaling and glycolysis respectively. Results: Clustering revealed over a dozen transcriptionally distinct CNS-resident and immune cell types, many of which have little prior study in ICH (Fig. 1b). 3,395 differentially expressed genes between hematoma and peripheral blood (p<0.05) were found in CD14 + monocytes and 932 in CD4 + effector T cells. Pathway analysis found upregulation of HIF signaling, glycolysis, and correlated networks of cytokine expression in the hematoma. The findings were significant across all immune populations but most prominent in myeloid cells (Fig. 1c). Inhibition of HIF and glycolysis in human macrophages in-vitro abrogated inflammatory and reparative cytokine production following inflammatory stimulation. In conclusion, this work highlights the interplay of inflammation and metabolism at a single cell level in ICH, contributing to knowledge of the immune response to brain injury.

Stages of the Inflammatory Response in Pathology and Tissue Repair after Intracerebral Hemorrhage

Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets

An Update on Inflammation in the Acute Phase of Intracerebral Hemorrhage

Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage

Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update

Rapid neuroinflammatory changes in human acute intracerebral hemorrhage

The hallmark and crosstalk of immune cells after intracerebral hemorrhage: Immunotherapy perspectives

The Crosstalk Between Immune Cells After Intracerebral Hemorrhage

Abstract 99: Single Cell RNA-Sequencing Reveals Array Of Immune Activation States In Intracerebral Hemorrhage

MyD88-TLR4-dependent choroid plexus activation precedes perilesional inflammation and secondary brain edema in a mouse model of intracerebral hemorrhage

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

Role of Neutrophils as Therapeutic Targets in Intracerebral Hemorrhage

Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage

Microglial Polarization and Inflammatory Mediators After Intracerebral Hemorrhage

Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage

Intracerebral haemorrhage — mechanisms, diagnosis and prospects for treatment and prevention

Neuroinflammation and blood-brain barrier breakdown in acute, clinical intracerebral hemorrhage

Pathophysiological Mechanisms and Potential Therapeutic Targets in Intracerebral Hemorrhage

Intracerebral Proinflammatory Cytokine Increase in Surgically Evacuated Intracerebral Hemorrhage: A Microdialysis Study

Secondary Hematoma Expansion and Perihemorrhagic Edema after Intracerebral Hemorrhage: From Bench Work to Practical Aspects

Cerebral Hemorrhage: Pathophysiology, Treatment, and Future Directions